More than 20 genetic loci have been associated with risk for Alzheimer’s disease (AD), but reported genome-wide significant loci do not account for all the estimated heritability and provide little information about underlying biological mechanisms. Genetic studies using intermediate quantitative traits such as biomarkers, or endophenotypes, benefit from increased statistical power to identify variants that may not pass the stringent multiple test correction in case–control studies. Endophenotypes also contain additional information helpful for identifying variants and genes associated with other aspects of disease, such as rate of progression or onset, and provide context to interpret the results from genome-wide association studies (GWAS)...
International audienceAbstract Alzheimer’s disease (AD) is the most prevalent neurodegenerative diso...
Characterization of the genetic landscape of Alzheimer’s disease (AD) and related dementias (ADD) pr...
International audienceAbstract Alzheimer’s disease (AD) is the most prevalent neurodegenerative diso...
More than 20 genetic loci have been associated with risk for Alzheimer’s disease (AD), but reported ...
More than 20 genetic loci have been associated with risk for Alzheimer’s disease (AD), but reported ...
Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nove...
Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nove...
Indiana University-Purdue University Indianapolis (IUPUI)Alzheimer’s Disease (AD) is one of the most...
Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nove...
Context: Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nov...
International audienceAbstract Alzheimer’s disease (AD) is the most prevalent neurodegenerative diso...
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and the most common form o...
International audienceAbstract Alzheimer’s disease (AD) is the most prevalent neurodegenerative diso...
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and the most common form o...
Characterization of the genetic landscape of Alzheimer’s disease (AD) and related dementias (ADD) pr...
International audienceAbstract Alzheimer’s disease (AD) is the most prevalent neurodegenerative diso...
Characterization of the genetic landscape of Alzheimer’s disease (AD) and related dementias (ADD) pr...
International audienceAbstract Alzheimer’s disease (AD) is the most prevalent neurodegenerative diso...
More than 20 genetic loci have been associated with risk for Alzheimer’s disease (AD), but reported ...
More than 20 genetic loci have been associated with risk for Alzheimer’s disease (AD), but reported ...
Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nove...
Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nove...
Indiana University-Purdue University Indianapolis (IUPUI)Alzheimer’s Disease (AD) is one of the most...
Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nove...
Context: Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as nov...
International audienceAbstract Alzheimer’s disease (AD) is the most prevalent neurodegenerative diso...
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and the most common form o...
International audienceAbstract Alzheimer’s disease (AD) is the most prevalent neurodegenerative diso...
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and the most common form o...
Characterization of the genetic landscape of Alzheimer’s disease (AD) and related dementias (ADD) pr...
International audienceAbstract Alzheimer’s disease (AD) is the most prevalent neurodegenerative diso...
Characterization of the genetic landscape of Alzheimer’s disease (AD) and related dementias (ADD) pr...
International audienceAbstract Alzheimer’s disease (AD) is the most prevalent neurodegenerative diso...